Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
about
New insights into the role of mitochondria in aging: mitochondrial dynamics and moreMitochondrial Quality Control and Muscle Mass MaintenanceSkeletal Muscle Mitochondrial Bioenergetics and Morphology in High Fat Diet Induced Obesity and Insulin Resistance: Focus on Dietary Fat SourceMitochondrial morphology-emerging role in bioenergeticsHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesMitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsMISC-1/OGC links mitochondrial metabolism, apoptosis and insulin secretionMitochondrial metabolism and the control of vascular smooth muscle cell proliferationALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosisIdentification of a novel modulator of thyroid hormone receptor-mediated action.Mitochondrial fusion is increased by the nuclear coactivator PGC-1betaH2O2-induced mitochondrial fragmentation in C2C12 myocytesSubjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activityMfn2 is critical for brown adipose tissue thermogenic functionMitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes.Role of mitofusin 2 in the renal stress responseDecreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver diseaseMorphological dynamics of mitochondria--a special emphasis on cardiac muscle cells.Mitochondrial dynamics in diabetes.Tissue-specific effects of bariatric surgery including mitochondrial functionOver-expressing mitofusin-2 in healthy mature mammalian skeletal muscle does not alter mitochondrial bioenergeticsMuscle oxidative capacity during IL-6-dependent cancer cachexia.Mitochondrial dysfunction and insulin resistance: an update.Mitophagy: therapeutic potentials for liver disease and beyond.Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes.High-lard and high-fish-oil diets differ in their effects on function and dynamic behaviour of rat hepatic mitochondria.Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus.Expression of key regulators of mitochondrial biogenesis in growth hormone receptor knockout (GHRKO) mice is enhanced but is not further improved by other potential life-extending interventions.Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells.Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesity-related diseases.Mitofusin 2-deficiency suppresses cell proliferation through disturbance of autophagy.Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions.Role of mitochondrial fission and fusion in cardiomyocyte contractility.The complex interplay between mitochondrial dynamics and cardiac metabolismMitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis.FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells.Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression.Association of polymorphisms in mitofusin-2 gene with type 2 diabetes in Han Chinese.Mitoflash altered by metabolic stress in insulin-resistant skeletal muscle.IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.
P2860
Q24600600-A9B5C161-ECCD-4848-8254-735165D7FEF9Q26770420-209AA06D-8020-4D8D-9829-B95D306D6D44Q26772781-4631449F-DDD0-4E41-81CE-3B3E6977E3B1Q26852770-35EAEE72-0085-45C7-96B1-99BAB9CD745DQ27005955-CE5AF5B2-76C5-4D21-A6BF-C3D83E001437Q27022354-BAF3D585-6C8E-4AA9-8F31-9EF495CB27C9Q27349840-FE12D289-BDE5-429B-A8D5-1EDFFF339D5DQ28083322-88779DC7-4E6B-4B5E-BD75-7277BF8719BCQ28386269-5515F027-7B43-4B2B-AF68-A973EFA7DBB0Q33306679-39D2A043-7843-4D8A-8BDC-04EED93D8835Q33381654-D7C82ED7-8D4D-4EB5-94F1-841D8646F91DQ33676657-0411B87A-BA70-4D36-A825-84A33AEC452FQ33683789-1D8D1162-9685-4676-98FC-D51C420F3EA5Q33749007-E450FF67-33E7-40DA-B527-DACCBE8D5928Q33940901-F6344B54-183D-4F9B-9008-1661438296EEQ34146617-AE4B70D9-48AD-4CB3-8312-DCFC312E7F09Q34200914-5E88F3FE-3F1E-445C-9F27-24F156F778DAQ34373141-818486B1-7BED-4AC7-A7EC-95D59CC05766Q34511749-DF2B8F9D-7E46-4C07-AF2B-0A50C8D560CDQ34512740-507E6CB8-AB14-447B-A3AC-A397AF7B5555Q34576868-C32C3134-4F41-4E74-A005-AC25485807F6Q34598672-9B29FA33-2AFB-464E-B962-885405462EADQ34668089-CE02487A-C4A9-4607-BF7D-FAD875A6616DQ34906459-1391AE03-E999-4BB7-BD46-BE69AF64F1F8Q35057168-3B7FF0A1-8408-4389-8DFE-65414A692F9DQ35129481-FBF45E55-AE9B-4BCB-8440-509B50810848Q35144163-70C050AF-9A81-4E91-8905-1A22AF04F795Q35211637-3487F953-6901-43B3-B00D-B4EDE529B336Q35529133-F22A9DC3-86EF-41F9-91AF-B2C24566EFF6Q35569606-710E742E-E021-4CA1-9967-253A6B2812B9Q35579701-84EA8600-468D-4398-A6EF-6BC3CB8A2219Q35607344-08937BCA-7156-488E-BB66-8A8AD858C5A1Q35639753-15B74659-B49F-4AA7-BC45-3F761ED2BAE3Q35777993-AED493FF-C144-4847-9612-90C278D19713Q35887283-02090904-D28E-41CA-88B6-C5C83D51715FQ35897895-C66C2350-962B-4E99-B973-A1F333D4F234Q35935796-18DC2F7B-79F3-431A-9A34-DABEA4D42F79Q36065816-08EE515C-60D9-40E9-99EB-2FA794A416EEQ36109269-8E0E6BCD-5280-49DD-9E19-F74CED108BF9Q36200582-3CCC2BA9-4DE7-42B4-BBC0-264BC4860D1E
P2860
Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@en
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@nl
type
label
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@en
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@nl
prefLabel
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@en
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@nl
P2093
P50
P921
P1433
P1476
Expression of Mfn2, the Charco ...... actor alpha and interleukin-6.
@en
P2093
Antonio Zorzano
Christelle Guillet
Daniel Bach
Geltrude Mingrone
Harriet Wallberg-Henriksson
Manuel Palacín
Marco Castagneto
Martine Laville
Melania Manco
Menotti Calvani
P304
P356
10.2337/DIABETES.54.9.2685
P407
P577
2005-09-01T00:00:00Z